EYENOVIA, INC. Files 8-K Report

TL;DR

EYENOVIA filed an 8-K, likely with financial updates. Check for details.

AI Summary

On January 28, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclosures related to the company's financial health and operations. No specific monetary transactions or new events were detailed in the provided excerpt.

Why It Matters

This filing signifies a routine disclosure by EYENOVIA, INC. to the SEC, potentially containing important financial information or updates for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, not indicating any immediate adverse events.

Key Players & Entities

• EYENOVIA, INC. (company) — Registrant
• January 28, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 001-38365 (identifier) — Commission File Number
• 47-1178401 (identifier) — IRS Employer Identification No.
• 295 Madison Avenue, Suite 2400, New York, NY 10017 (address) — Principal Executive Offices
• ( 833 ) 393-6684 (phone_number) — Registrant's Telephone Number

FAQ

Key Financial Figures

• $0.0001 — on which registered) Common stock, $0.0001 par value EYEN The Nasdaq Stock Mar

Filing Documents

• tm254557d1_8k.htm (8-K) — 29KB
• tm254557d1_ex99-1.htm (EX-99.1) — 10KB
• 0001104659-25-006697.txt ( ) — 213KB
• eyen-20250128.xsd (EX-101.SCH) — 3KB
• eyen-20250128_lab.xml (EX-101.LAB) — 33KB
• eyen-20250128_pre.xml (EX-101.PRE) — 22KB
• tm254557d1_8k_htm.xml (XML) — 4KB

01

Item 8.01. Other Events. On January 28, 2025, Eyenovia, Inc. (the "Company") announced that its board of directors approved a reverse stock split at a ratio of 1-for-80, such that every 80 shares of the Company's common stock, $0.0001 par value per share (the "Common Stock") will be combined into one issued and outstanding share of Common Stock (the "Reverse Stock Split"). The Reverse Stock Split will be effective at 4:00 p.m., Eastern Time, on January 31, 2025. At the market open on February 3, 2025, the Common Stock will begin trading on a post-split basis under new CUSIP number 30234E 203. The Reverse Stock Split is being effected to enable the Company to regain compliance with the minimum bid price required to remain listed on the Nasdaq Capital Market. The Reverse Stock Split will affect all stockholders uniformly and will not affect any stockholder's percentage ownership interests in the Company, except to the extent that any cash payments are made in lieu of fractional shares. Fractional shares will not be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive a fractional share will be entitled to receive a cash payment in lieu of such fractional share. On January 28, 2025, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Forward-Looking Statements

Forward-Looking Statements Except for historical information, all the statements, expectations and assumptions contained in this Current Report on Form 8-K are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements relating to the Company's future activities or other future events or conditions, including those relating to the Company's planned Reverse Stock Split and the timing thereof, the impact of the Reverse Stock Split on the Company's stockholders, including any adjustments that may result from the treatment of fractional shares, and the Company's ability to regain compliance with the listing rules of the Nasdaq and maintain its continued listing. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and in some cases are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents which the Company files with the U.S. Securities and Exchange Commission. Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, the Company does not undertake any obligation to update any forward-looking statements.

01

Item 9.01. Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 28, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYENOVIA, INC. Date: January 28, 2025 /s/ Michael Rowe Michael Rowe Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR